The European Federation of National Associations of Orthopaedics and Traumatology (EFORT) welcomes the European Commission’s proposal 2025/0404 (COD) for a targeted evaluation and revision of the Medical Devices Regulation (MDR) and In Vitro Diagnostics Regulation (IVDR). EFORT, representing 41 National Orthopaedic and Traumatology Societies accross Europe, and by this more than 60.000 clinical active orthopaedic […]
EFORT Today March 2026 | EDITORIAL
March 13, 2026 By
Dear Orthopaedic and Trauma community, Dear friends, The upcoming EFORT Congress in Málaga will focus on “Innovations and Transdisciplinarity in the Orthopaedic Future”. The Scientific Chair and the EFORT Board thrive to offer you the opportunity to exchange with leading European Orthopaedic Surgeons but also discuss the latest Scientific development in Orthopaedic and Traumatology. The […]
EFORT Today February 2026 | EDITORIAL
February 19, 2026 By
Dear Orthopaedic and Trauma community, The last few years the Board handled some challenges since the covid-years to revitalise EFORT, with positive results! We refocused our activities on four pillars: Science: through its annual Scientific Congress. Education: through the EFORT Educational Webinars and the EBOT Exam. Research: through its peer-review journal, scientific networks and EU […]
EU Affairs: What’s going on in Brussels early 2026?
January 25, 2026 By
You might have noticed that issues discussed in Brussels, seem at a good distance from daily practice in Orthopaedic and Traumatology. This perception is often shared by many medical specialists. Still, many issues debated and discussed in Brussels have an impact on daily practise, however indirect one. For instance, the discussions over the Medical Device […]
Recommended methodologies for clinical investigations of high-risk medical devices—Conclusions from the European Union CORE–MD Project
September 16, 2025 By
Brussels, Belgium | 16 September 2025 The CORE-MD (Coordinating Research and Evidence for high-risk Medical Devices) consortium is publishing new consensus recommendations today in The Lancet Regional Health Europe, that set out scientifically robust methodologies for clinical investigations of high-risk medical devices. These recommendations respond directly to a request from the European Commission to provide […]
Health is wealth: policy makers must preserve investment to protect the health of EU citizens
May 5, 2025 By
Together with a broad range of health stakeholders, EFORT jointly call on policy makers to preserve funding for key health policy and research funding instruments, such as EU4Health and the Health Cluster in Horizon Europe. Policy makers are likely to consider cutting the budget for the next Multiannual Financial Framework as from 2028 of key […]
BioMed Alliance shares new set of recommendations on key challenges in system for medical devices & IVDs
April 2, 2025 By
The BioMed Alliance in Europe represents medical societies at the European level. It is active to voice the concerns and expectations of medical specialists and raise awareness on the need to involve healthcare professionals in ongoing health-related issues. EFORT is an active member of the Biomed Alliance and has been contributing to several initiatives on […]
Message in support of the populations affected by the earthquake in the regions of Türkiye and Syria
February 16, 2023 By
EFORT Head Office | Rolle, Switzerland, 16 February 2023 The European Federation of National Associations of Orthopaedics and Traumatology EFORT expresses its sympathy and support to all those people affected by the devastating earthquake disaster in the regions of Türkiye and Syria. Our thoughts also are with physicians, rescue teams and other health professionals deployed […]
Better know hyaluronic acid
June 24, 2022 By
An interview with Hyuntae Jung, Life Sciences R&D of LG Chem Hyaluronic acid is everywhere you look (literally in your eyes and your skin), and with its exponential growth as a component in treatments from cosmetics to oncological drug delivery systems, we focus on issues surrounding its clinical application for the treatment of osteoarthritis. Dr. […]
If it’s not broken don’t fix it: Top bone substitute material for effective antibiotic and bone defect treatment outcomes
June 24, 2022 By
A Q&A with Professor Dr. Christian Heiss Professor Dr. h.c. Christian Heiss, head of the Department of Trauma, Hand and Reconstructive Surgery at the University Hospital of Giessen, Germany gave information to EFORT about the advantages and disadvantages of a synthetic, biodegradable and osteoconductive bone substitute material known as PerOssal® – a degradable composite of […]
